These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7982642)

  • 1. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis.
    Moradpour D; Altorfer J; Flury R; Greminger P; Meyenberger C; Jost R; Schmid M
    Hepatology; 1994 Dec; 20(6):1437-41. PubMed ID: 7982642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine-induced cholestatic liver disease with ductopenia.
    Chlumská A; Curík R; Boudová L; Mukensnabl P; Klvana P
    Cesk Patol; 2001 Jul; 37(3):118-22. PubMed ID: 11669021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
    Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
    Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline-induced bile duct paucity and prolonged cholestasis.
    Hunt CM; Washington K
    Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis, a vanishing bile duct disease.
    van Berge Henegouwen GP
    Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059
    [No Abstract]   [Full Text] [Related]  

  • 7. Xenobiotic-induced liver injury and fibrosis.
    Österreicher CH; Trauner M
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A contribution on the diagnosis of bile duct atresia and hypoplasia in infants (author's transl)].
    Gathmann H
    Acta Hepatogastroenterol (Stuttg); 1973; 20(1):24-35. PubMed ID: 4757775
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive bile duct injury after thiabendazole administration.
    Manivel JC; Bloomer JR; Snover DC
    Gastroenterology; 1987 Aug; 93(2):245-9. PubMed ID: 3297909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Bile Duct Ligation as Model for Secondary Biliary Cirrhosis.
    Van Campenhout S; Van Vlierberghe H; Devisscher L
    Methods Mol Biol; 2019; 1981():237-247. PubMed ID: 31016658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
    Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
    Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine-induced vanishing bile duct syndrome in a child.
    Bhayana H; Appasani S; Thapa BR; Das A; Singh K
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice.
    Nakanuma Y; Hoso M; Mizuno Y; Unoura M
    Liver; 1988 Dec; 8(6):319-24. PubMed ID: 3216771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced Bile Duct Injury - A Short Review.
    Dobreva I; Karagyozov P
    Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis: is there still a place for histological evaluation?
    Nakanuma Y
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):e1-2. PubMed ID: 24029741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.